Connect with us

health and wellness

US health care is rife with high costs and deep inequities, and that’s no accident

Published

on

Last Updated on July 20, 2025 by Daily News Staff

A public health historian explains how the system was shaped to serve profit and politicians

health care
Concessions to the private sector are one reason why health care is so costly.
FS Productions/Tetra images via Getty Images

Zachary W. Schulz, Auburn University

A few years ago, a student in my history of public health course asked why her mother couldn’t afford insulin without insurance, despite having a full-time job. I told her what I’ve come to believe: The U.S. health care system was deliberately built this way.

People often hear that health care in America is dysfunctional – too expensive, too complex and too inequitable. But dysfunction implies failure. What if the real problem is that the system is functioning exactly as it was designed to? Understanding this legacy is key to explaining not only why reform has failed repeatedly, but why change remains so difficult.

I am a historian of public health with experience researching oral health access and health care disparities in the Deep South. My work focuses on how historical policy choices continue to shape the systems we rely on today.

By tracing the roots of today’s system and all its problems, it’s easier to understand why American health care looks the way it does and what it will take to reform it into a system that provides high-quality, affordable care for all. Only by confronting how profit, politics and prejudice have shaped the current system can Americans imagine and demand something different.

Decades of compromise

My research and that of many others show that today’s high costs, deep inequities and fragmented care are predictable features developed from decades of policy choices that prioritized profit over people, entrenched racial and regional hierarchies, and treated health care as a commodity rather than a public good.

Over the past century, U.S. health care developed not from a shared vision of universal care, but from compromises that prioritized private markets, protected racial hierarchies and elevated individual responsibility over collective well-being.

Employer-based insurance emerged in the 1940s, not from a commitment to worker health but from a tax policy workaround during wartime wage freezes. The federal government allowed employers to offer health benefits tax-free, incentivizing coverage while sidestepping nationalized care. This decision bound health access to employment status, a structure that is still dominant today. In contrast, many other countries with employer-provided insurance pair it with robust public options, ensuring that access is not tied solely to a job.

In 1965, Medicare and Medicaid programs greatly expanded public health infrastructure. Unfortunately, they also reinforced and deepened existing inequalities. Medicare, a federally administered program for people over 64, primarily benefited wealthier Americans who had access to stable, formal employment and employer-based insurance during their working years. Medicaid, designed by Congress as a joint federal-state program, is aimed at the poor, including many people with disabilities. The combination of federal and state oversight resulted in 50 different programs with widely variable eligibility, coverage and quality.

[youtube https://www.youtube.com/watch?v=0RR-Q8D131s?wmode=transparent&start=0]
A brief history of Medicaid expansion.

Southern lawmakers, in particular, fought for this decentralization. Fearing federal oversight of public health spending and civil rights enforcement, they sought to maintain control over who received benefits. Historians have shown that these efforts were primarily designed to restrict access to health care benefits along racial lines during the Jim Crow period of time.

Advertisement
Get More From A Face Cleanser And Spa-like Massage

Bloated bureaucracies, ‘creeping socialism’

Today, that legacy is painfully visible.

States that chose not to expand Medicaid under the Affordable Care Act are overwhelmingly located in the South and include several with large Black populations. Nearly 1 in 4 uninsured Black adults are uninsured because they fall into the coverage gap – unable to access affordable health insurance – they earn too much to qualify for Medicaid but not enough to receive subsidies through the Affordable Care Act’s marketplace.

The system’s architecture also discourages care aimed at prevention. Because Medicaid’s scope is limited and inconsistent, preventive care screenings, dental cleanings and chronic disease management often fall through the cracks. That leads to costlier, later-stage care that further burdens hospitals and patients alike.

Meanwhile, cultural attitudes around concepts like “rugged individualism” and “freedom of choice” have long been deployed to resist public solutions. In the postwar decades, while European nations built national health care systems, the U.S. reinforced a market-driven approach.

Publicly funded systems were increasingly portrayed by American politicians and industry leaders as threats to individual freedom – often dismissed as “socialized medicine” or signs of creeping socialism. In 1961, for example, Ronald Reagan recorded a 10-minute LP titled “Ronald Reagan Speaks Out Against Socialized Medicine,” which was distributed by the American Medical Association as part of a national effort to block Medicare.

The health care system’s administrative complexity ballooned beginning in the 1960s, driven by the rise of state-run Medicaid programs, private insurers and increasingly fragmented billing systems. Patients were expected to navigate opaque billing codes, networks and formularies, all while trying to treat, manage and prevent illness. In my view, and that of other scholars, this isn’t accidental but rather a form of profitable confusion built into the system to benefit insurers and intermediaries.

[youtube https://www.youtube.com/watch?v=KqBAIPKS2pk?wmode=transparent&start=0]
President Donald Trump’s proposed cuts would reduce Medicaid spending by about US$700 billion.

Coverage gaps, chronic disinvestment

Even well-meaning reforms have been built atop this structure. The Affordable Care Act, passed in 2010, expanded access to health insurance but preserved many of the system’s underlying inequities. And by subsidizing private insurers rather than creating a public option, the law reinforced the central role of private companies in the health care system.

The public option – a government-run insurance plan intended to compete with private insurers and expand coverage – was ultimately stripped from the Affordable Care Act during negotiations due to political opposition from both Republicans and moderate Democrats.

When the U.S. Supreme Court made it optional in 2012 for states to offer expanded Medicaid coverage to low-income adults earning up to 138% of the federal poverty level, it amplified the very inequalities that the ACA sought to reduce.

These decisions have consequences. In states like Alabama, an estimated 220,000 adults remain uninsured due to the Medicaid coverage gap – the most recent year for which reliable data is available – highlighting the ongoing impact of the state’s refusal to expand Medicaid.

Advertisement
Get More From A Face Cleanser And Spa-like Massage

In addition, rural hospitals have closed, patients forgo care, and entire counties lack practicing OB/GYNs or dentists. And when people do get care – especially in states where many remain uninsured – they can amass medical debt that can upend their lives.

All of this is compounded by chronic disinvestment in public health. Federal funding for emergency preparedness has declined for years, and local health departments are underfunded and understaffed.

The COVID-19 pandemic revealed just how brittle the infrastructure is – especially in low-income and rural communities, where overwhelmed clinics, delayed testing, limited hospital capacity, and higher mortality rates exposed the deadly consequences of neglect.

A system by design

Change is hard not because reformers haven’t tried before, but because the system serves the very interests it was designed to serve. Insurers profit from obscurity – networks that shift, formularies that confuse, billing codes that few can decipher. Providers profit from a fee-for-service model that rewards quantity over quality, procedure over prevention. Politicians reap campaign contributions and avoid blame through delegation, diffusion and plausible deniability.

This is not an accidental web of dysfunction. It is a system that transforms complexity into capital, bureaucracy into barriers.

Patients – especially the uninsured and underinsured – are left to make impossible choices: delay treatment or take on debt, ration medication or skip checkups, trust the health care system or go without. Meanwhile, I believe the rhetoric of choice and freedom disguises how constrained most people’s options really are.

Other countries show us that alternatives are possible. Systems in Germany, France and Canada vary widely in structure, but all prioritize universal access and transparency.

Understanding what the U.S. health care system is designed to do – rather than assuming it is failing unintentionally – is a necessary first step toward considering meaningful change.

Zachary W. Schulz, Senior Lecturer of History, Auburn University

This article is republished from The Conversation under a Creative Commons license. Read the original article.

Advertisement
Get More From A Face Cleanser And Spa-like Massage

health and wellness

How Clinical Trials Really Work: Understanding the 4 Phases

Understanding how clinical trials work can help demystify the experience, while the research itself helps answer important questions about diseases, treatment options and more. If you, your healthcare team and the study researchers decide an experimental drug trial is right for you, different questions will be answered depending on which phase you participate in.

Published

on

How Clinical Trials Really Work: Understanding the 4 Phases

How Clinical Trials Really Work: Understanding the 4 Phases

(Feature Impact) The idea of participating in a clinical trial can feel overwhelming, especially if you aren’t sure what’s actually involved in the process. Understanding how clinical trials work can help demystify the experience, while the research itself helps answer important questions about diseases, treatment options and more.

According to a study by the Crohn’s & Colitis Foundation, nearly 1 in 100 Americans has inflammatory bowel disease (IBD), a term encompassing a group of conditions that includes Crohn’s disease and ulcerative colitis. These disorders affect the gastrointestinal tract and cause inflammation of the intestines, which can lead to symptoms and sometimes more complicated issues throughout the body. Research into this condition has the potential to change lives, including those of the participants themselves, yet many clinical trials face delays due to lack of enrollment.

“We need more people to get involved in clinical trials, especially those from underrepresented communities, including people of color and older adults, who have some of the highest rates of chronic disease,” said Dr. Ruby Greywoode, a gastroenterologist at Montefiore Medical Center.

Clinical trials can take many forms including medication studies, medical tests, investigating the role of diet in disease management or examining the emotional impact of living with a condition such as IBD. Each trial is typically divided into four phases, which all build on each other but are conducted separately.

If you, your healthcare team and the study researchers decide an experimental drug trial is right for you, different questions will be answered depending on which phase you participate in.

Phase 1: Is the Drug Safe to Use?

The first phase of a clinical trial is the smallest and often conducted among a group of healthy people who don’t have the condition in question. Researchers want to know how the human body reacts to the medication, determine safe dosage ranges and identify potential side effects.

Phase 2: Is the Drug Effective?

Once a drug has been evaluated for overall safety in healthy people, the clinical trial moves on to test the treatment in a slightly larger group of people. Those participating in this phase have the condition for which the new treatment is being developed. For instance, a phase 2 IBD clinical trial might give the drug to 100 people with IBD to see whether it works or causes any short-term side effects. Participants are randomly assigned to different treatment groups, which may involve different dosages or placebos (not active treatment).

18243 detail embed2Phase 3: Does It Work Better Than Currently Available Treatments?

If the second phase yields positive results, the study expands again to test the new drug against current treatment options. A phase 3 clinical trial lasts longer and involves more participants than the first two phases as researchers try to gain as much information as possible about how the drug affects different kinds of people, whether it’s better than standard treatments or placebos and what side effects may arise over a longer period of time.

At the end of this phase, the company decides whether the trial results are strong enough to submit an application to the FDA, at which point the treatment will be reviewed and potentially approved.

Phase 4: How Does the Drug Work in Real Life?

Research usually doesn’t end when a drug gets approved. Instead, it moves into the fourth phase, where companies monitor the ongoing real-world uses and effects of the medication. This can involve following thousands of patients for several years to gather as much information as possible.

If you’re one of the millions of people living with IBD in the U.S., clinical trials offer hope for a future with more treatments, less pain and healthier lives. That’s why the Crohn’s & Colitis Foundation wants to make clinical trials less mysterious, more accessible and more representative of the real people affected by these conditions.

Advertisement
Get More From A Face Cleanser And Spa-like Massage

Talk to your healthcare professional about whether a clinical trial could be right for you and explore IBD research opportunities at CrohnsColitisFoundation.org.

Clinical Trial FAQs

What is the average length of a clinical trial?

The length of clinical trials vary. They can be as short as a month or as long as one year or more. Generally, the earlier the phase, the shorter the trial period. How do you identify clinical trials you’re eligible for?

Eligibility criteria differ from study to study and may include factors like age, gender, medical history and current health status. For instance, some IBD studies may be looking for patients with mild symptoms, while others want to test treatments for moderate to severe disease. If you’re interested in a particular trial, review the criteria to see if you qualify to participate.

Is it free to participate in clinical trials?

Most clinical trials are federally or privately funded, so there is typically no cost to the participant. Associated costs like travel, time off work and childcare may or may not be covered by the trial sponsor, so it’s worth confirming these details before committing.

What if you enroll in a trial then change your mind?

You’re free to withdraw from a clinical trial at any time. If you drop out during testing, you may be asked to come in for follow-up visits to ensure your safety.

If the treatment helps, can you keep using it after the trial ends?

It depends. Some trial sponsors allow participants to continue receiving the drug voluntarily, while others only make it available after it’s been approved by the FDA.

How can you get involved in clinical trials?

Talk to your doctor about whether participating in a clinical trial may be right for you. If you’re interested in IBD clinical trials, you and your doctor can search for opportunities at crohnscolitisfoundation.org/clinical-trials-community.

“Clinical trials give patients a real way to shape the future of treatment,” Greywoode said. “It’s not just about their own care; it can help others, too. Talking openly with your doctor can help you feel more confident about getting involved.”

Photos courtesy of Shutterstock

collect?v=1&tid=UA 482330 7&cid=1955551e 1975 5e52 0cdb 8516071094cd&sc=start&t=pageview&dl=http%3A%2F%2Ftrack.familyfeatures
track

SOURCE:

Crohn’s & Colitis Foundation

Advertisement
Get More From A Face Cleanser And Spa-like Massage
https://stmdailynews.com/menopause-changes-your-mouth-most-women-have-no-idea/
Continue Reading

Health

Radon is the second leading cause of lung cancer. 8 in 10 US adults have never tested their home for it

Decades of public health campaigns have reinforced the connection between smoking and lung cancer, helping people understand that their choices can influence their health. Despite radon being the second-leading cause of lung cancer, many have never tested their home for it.

Published

on

Radon is the second leading cause of lung cancer. 8 in 10 US adults have never tested their home for it

Radon is the second leading cause of lung cancer. 8 in 10 US adults have never tested their home for it

(Sheeka Sanahori) Avoid tobacco products. Eat a healthy diet. Get recommended cancer screenings. Most U.S. adults recognize these behaviors as ways to lower their cancer risk or catch cancer early. Decades of public health campaigns have reinforced the connection between smoking and lung cancer, helping people understand that their choices can influence their health.

But U.S. adults are far less likely to recognize a risk factor they can’t control through daily habits. Radon – an odorless, invisible gas that forms naturally in the ground – is the second leading cause of lung cancer, but new research from the Prevent Cancer Foundation finds that 8 in 10 U.S. adults have never tested their home for radon. The findings are based on the Foundation’s annual Early Detection Survey of more than 7,000 U.S. adults, conducted in January 2026.

With recent high-profile lung cancer cases, such as the October diagnosis of Pope Leo XIV, who is not known to have a history of smoking cigarettes, more people are paying attention to other risk factors for lung cancer, especially for people who have never smoked.

18265 B detail embed2

Testing for radon is last on the list

When asked about preventive behaviors, 77.5% say avoiding tobacco lowers their cancer risk. Three out of four say eating a healthy diet and getting routine cancer screenings make a difference, too. More than half also named regular exercise, limiting alcohol and protecting themselves from harmful UV rays.

Testing their home for radon ranked last on the list of preventive behaviors, with only 28% listing it as a way to reduce their cancer risk.

18265 C detail embed3

Most homes go untested in every region

Radon hasn’t reached the same level of public awareness as tobacco use, diet and exercise. U.S. adults appear to overlook an environmental risk that could be inside their own homes. Eighty percent of U.S. adults report never having their homes tested for radon, and only 12% have tested within the last five years. The U.S. Environmental Protection Agency (EPA) recommends testing every two years.

In the Northeast, about 7 in 10 people (72%) have never tested their home for radon. That percentage increases for the Midwest (79%), West (82%) and South (83%). Unlike cigarettes, radon does not produce smoke and is odorless, so a test is the only way to detect its presence.

18265 D detail embed4

What it takes to find out

Radon can enter homes through the ground when uranium underneath decays. Once it’s inside, it gets trapped. People can live with high radon levels without knowing it, in older homes and new construction alike. Breaking ground on undisturbed land during construction can release more radon.

Renters can either test themselves or ask their landlord whether the home has been tested and request the results. Landlord requirements vary by state.

Test kits are inexpensive and available online and at home improvement stores. The EPA recommends taking action to reduce radon levels at 4 picocuries per liter (pCi/L) or higher, and notes that levels below that may still carry risk. If levels are high, a mitigation system can bring them down.

Beyond radon, the EPA and other health authorities cite avoiding tobacco and secondhand smoke as the most significant steps people can take to lower lung cancer risk, along with following screening guidelines based on personal risk factors.

Methodology

The Prevent Cancer Foundation commissioned Atomik Research to conduct the Foundation’s fourth annual Early Detection Survey of U.S. adults. The study consists of an online survey questionnaire, which includes several repeated measures from a previous year’s questionnaire and a primary data set gathered from a sample of 7,510 adults located throughout the United States. The sample consists of adults 21 years of age or older, and researchers implemented several demographic-based quotas in order to achieve sample characteristics similar to the overall U.S. population of adults 21 and older.

Researchers controlled for demographic variables such as biological sex, age group classification, race/ethnicity, parental status, geographic region, employment status and community classifications (e.g., urban or rural classification).

Advertisement
Get More From A Face Cleanser And Spa-like Massage

The margin of error of the overall sample is +/-1 percentage point with a confidence level of 95%. Fieldwork took place between Jan. 10 and Jan. 30, 2026. Atomik Research is an independent market research agency.

Percentages may not add up to 100% due to computer rounding, and/or the acceptance of multiple responses.

Photo courtesy of Shutterstock (family playing)

collect?v=1&tid=UA 482330 7&cid=1955551e 1975 5e52 0cdb 8516071094cd&sc=start&t=pageview&dl=http%3A%2F%2Ftrack.familyfeatures.com%2F18265%2F10675&dt=RADON IS THE SECOND LEADING CAUSE OF LUNG CANCER
track

SOURCE:

Prevent Cancer Foundation

https://stmdailynews.com/beyond-the-piggy-bank-how-to-build-your-childs-financial-future/
Continue Reading

Women's Health

Menopause changes your mouth. Most women have no idea.

Menopause changes your mouth: Many women are familiar with the most talked-about symptoms of menopause – hot flashes, disrupted sleep, brain fog and mood swings. Far fewer know that dry mouth and sensitive teeth belong on that list too.

Published

on

18132 detail intro

Menopause changes your mouth. Most women have no idea.

(Sheeka Sanahori) Many women are familiar with the most talked-about symptoms of menopause – hot flashes, disrupted sleep, brain fog and mood swings. Far fewer know that dry mouth and sensitive teeth belong on that list too.

There’s a name for it: menopause mouth. According to survey data from Delta Dental Insurance Company, 83% of women 40 and older in menopause aren’t aware of any of its symptoms.

18132 detail embed2

What menopause mouth feels like

Forty percent say they have noticed an increase in dry mouth. Another 27% have noticed more tooth sensitivity in recent months, and 26% say things taste different than they used to. You tell yourself it’s something else. You’re not drinking enough water; you’ve been brushing too hard. Menopause isn’t the first thing that comes to mind.

It adds up. Forty-five percent say oral symptoms associated with menopause, such as tooth pain, dry mouth or gum inflammation, take a toll on their confidence, mood or mental health.

18132 detail embed3

Menopause affects the whole body, mentally and physically. So why is the mouth left out?

Even after learning about this connection, 30% of women say they can’t find information about menopause-related oral health concerns. It isn’t that no one is willing to discuss it.

What makes the conversation hard to start

Three-quarters of dentists say they are comfortable discussing menopause with patients. They just want to know who they’re talking to. Most say they would want more patient history, or to know a patient was in menopause, before raising the subject. Forty-five percent say they would not bring up how menopause affects oral health unless a patient asked.

Dentists also believe that patients are already informed. Ninety-four percent say their patients are at least somewhat aware that menopause can affect oral health. So a patient says nothing about her dry mouth, because it doesn’t seem like a dental problem. The dentist doesn’t bring it up either, assuming someone already has.

18132 detail embed4

Women are asking for the information

Nearly nine in 10 women say it would help to receive specific instructions during dental visits about managing oral health during menopause. And 69% say they would be more likely to book an appointment if a primary care provider or OB-GYN had told them menopause affects oral health.

No matter who brings it up, the conversation is one worth having. Hormonal changes during menopause can increase the risk of tooth loss or tooth decay, gum disease, receding gumline or loss of jawbone density. Discussing new oral symptoms with a dentist can help women identify potential problems and address them early.

How to start the conversation with your dentist

Your dentist probably doesn’t know you’re in menopause. Start there.

Questions worth asking:

  • “Could the changes I’m noticing be related to menopause?”
  • “I haven’t had a cavity in 30 years, and now I have two. Could that be tied to hormonal changes?”
  • “What can I do about dry mouth?”
  • “Are there symptoms I should watch for?”
  • “Should I adjust my oral care routine?”

Any one of these questions can get the conversation started.

Methodology

Delta Dental Insurance Company commissioned Atomik Research to conduct two online surveys between June 25 and July 2, 2025.

The first surveyed 200 dentists throughout the United States. The margin of error is +/- 7 percentage points with a 95% confidence level.

Advertisement
Get More From A Face Cleanser And Spa-like Massage

The second surveyed 1,511 women ages 40 or older throughout the United States. To qualify, participants had to indicate they are in perimenopause, menopause or post-menopause. Those who were not sure which stage they were in, or who indicated they were not yet in one of the three stages, were excused from participation. The margin of error is +/- 3 percentage points with a 95% confidence level

Atomik Research, part of 4media group, is an independent market research agency.

Photo courtesy of Shutterstock

collect?v=1&tid=UA 482330 7&cid=1955551e 1975 5e52 0cdb 8516071094cd&sc=start&t=pageview&dl=http%3A%2F%2Ftrack.familyfeatures.com%2F18132%2F10661&dt=MENOPAUSE CHANGES YOUR MOUTH. MOST WOMEN HAVE NO IDEA
track

SOURCE:

Delta Dental Insurance Company

https://stmdailynews.com/beyond-hot-flashes-5-things-women-wish-everyone-knew-about-menopause-2/
Continue Reading

Trending